WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS
MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.
MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.
TOGETHER WE CAN BUILD A BRIGHTER FUTURE
MEDSIR ONCOCLÍNICAS ACADEMY
MEDSIR and Oncoclínicas & Co. teamed up to launch the MEDSIR Oncoclínicas Academy, an educational project aiming to elevate clinical research expertise globally. In the past edition, a group of Medical Oncologists specialized in breast cancer from Brazil, attended a 5-day program in Barcelona, Spain.
The hands-on experience in a hospital and the workshops led by experts and KOLs, resulted in an increase of the group’s expertise in the design and management of clinical trials, offering both a scientific and operational perspective while delineating their roles and responsibilities as Principal Investigators.
MEDSIR IN NUMBERS
>35
INDUSTRY FUNDERS
>187
SITES
>59
TRIALS DEVELOPED
>432
RESEARCH
COLLABORATORS
>862
IDEAS
GENERATED
>108
STAFF
DEDICATED
>2455
PATIENTS
RECRUITED
OUR STUDIES
Some examples of MEDSIR ideas matured into strategic clinical trials.